MSTN and Duchenne muscular dystrophy: Because of high homology between myostatin and other growth factors of the transforming growth factor β (TGF-β) family, high specificity against myostatin is necessary to avoid previously observed side effects of the first clinically tested compounds in Duchenne muscular dystrophy (DMD) (gingival bleeding, telangiectasias, and hormonal level changes).99